Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.630
+0.080 (5.16%)
At close: Oct 13, 2025, 4:00 PM EDT
1.630
0.00 (0.00%)
After-hours: Oct 13, 2025, 6:30 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $6.56 million as of October 13, 2025. Its market cap has decreased by -42.26% in one year.
Market Cap
6.56M
Enterprise Value
5.17M
1-Year Change
-42.26%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $6.56M, a decrease of -97.60%. That is a compound annual growth rate of -61.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 6.24M | -71.91% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |